Skip to content
Screener

Balchem BCPC Q3 2026 earnings

Reported October 23, 2026 · Before market open

Revenue$290.7MBeat by $1.4M
Adjusted EPS$1.57Beat by $0.14
Revenue estimate$289.2M
EPS estimate$1.43
“Balchem delivered another excellent quarter, with healthy growth across all three of our reporting segments and record consolidated quarterly net sales, net earnings, and adjusted EBITDA.”
Ted Harris

Next report

Date not yet announced

Financials

Q3 2026

Income statement

See full
Revenue$290.7M+8.6%
Gross profit$105.7M+10.7%
Operating income$62.4M+14.4%
Net income$46.7M+16.0%
EPS (diluted)$1.46+17.7%

Balance sheet

See full
Cash & equivalents$66.3M+1.8%
Total debt$40.4M+2.6%
Total equity$1.3B+2.2%
Total assets$1.7B+2.6%

Cash flow

See full
Operating cash flow$69.8M+6.4%

Valuation & ratios

Valuation

as of 10/30/26
See full
Market cap$5.43B+8.9%
Enterprise value$5.41B+9.0%
P/E31.8×-1.6×
P/S4.9×0.0×

Profitability

See full
Gross margin36.5%+0.6pp
Operating margin20.7%+0.5pp
Net margin15.4%+0.7pp

Returns & leverage

See full
Return on equity13%+1.0pp
Debt / equity0×0.0×
Current ratio2.5×-0.3×

Segments

By segment

See full
Human Nutrition and Health$188.2M+8.1%
Animal Nutrition and Health$63.0M+11.7%
Specialty Products$37.3M+4.5%

FAQ

When did Balchem report Q3 2026 earnings?
Balchem (BCPC) reported Q3 2026 earnings on October 23, 2026 before market open.
What were Balchem's Q3 2026 revenue and EPS?
Balchem reported revenue of $290.7M and adjusted eps of $1.57 for Q3 2026.
Did Balchem beat estimates in Q3 2026?
Revenue beat the consensus estimate of $289.2M by $1.4M. EPS beat the consensus estimate of $1.43 by $0.14.
Where can I find Balchem's Q3 2026 SEC filings?
You can read the 8-K earnings release (0000009326-26-000032) and the 10-Q periodic report (0000009326-26-000035) directly on SEC EDGAR. The filing index links above go to sec.gov.